Becton Dickinson and Co vs JPMorgan Ultra Short Income ETF — how do they compare? Becton Dickinson and Co trades at $181.29 (market cap $49.41B), while JPMorgan Ultra Short Income ETF trades at $50.46. The key difference: Becton Dickinson and Co pays a 2.32% dividend while JPMorgan Ultra Short Income ETF pays none, and Becton Dickinson and Co is trading nearer its 52-week high, JPMorgan Ultra Short Income ETF nearer its low. Which is the better fit depends on your goals.
| BDX | JPST | |
|---|---|---|
Market Cap | $49.41B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $185.39 | $50.78 |
52-Week Low | $138.62 | $50.40 |
Enterprise Value | $65.51B | — |
Dividend Yield | 2.32% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
JPST (JPMorgan Ultra-Short Income ETF) trades at $50.44, showing minimal daily movement with a 0.08% gain. The technical picture remains bearish with moving averages signaling caution, though the RSI suggests potential oversold conditions. Recent institutional activity shows growing interest, with Financial Management Professionals increasing their stake by 4.7% in Q2 2026. The fund maintains consistent dividend distributions of $0.17 per share, providing stable income for risk-averse investors seeking short-term bond exposure.
As an ultra-short income ETF, JPST offers conservative investors a cash-alternative with slightly higher yields than T-bills. The fund's stability and consistent dividends make it attractive for parking cash between investments or during uncertain rate environments. However, rising interest rates and inflation pressures pose headwinds for short-term bond performance. The ETF's bearish technical signals warrant monitoring, though its defensive positioning provides downside protection in volatile markets.
Trailing returns across standard periods
Latest headlines on both assets
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →JPST is an actively managed ETF that invests in short-term, investment-grade fixed income securities. It aims to provide current income and capital preservation while maintaining high liquidity.
Read more on JPST →